Nemaura Medical (NMRD) Stock Forecast, Price Target & Predictions
NMRD Stock Forecast
Nemaura Medical stock forecast is as follows: a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
NMRD Analyst Ratings
According to 2 Wall Street analysts, Nemaura Medical's rating consensus is 'Buy'. The analyst rating breakdown for NMRD stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jul 17, 2023 | EF Hutton | Buy | Buy | Hold |
| Aug 19, 2022 | Piper Sandler | Buy | Buy | Hold |
Nemaura Medical's last stock rating was published by EF Hutton on Jul 17, 2023. The company gave NMRD a "Buy" rating, the same as its previous rate.
Nemaura Medical Financial Forecast
Nemaura Medical Revenue Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Sep 21 | |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Avg Forecast | - | $200.00K | $300.00K | $100.00K | $100.00K | $200.00K |
| High Forecast | - | $200.00K | $300.00K | $100.00K | $100.00K | $240.00K |
| Low Forecast | - | $200.00K | $300.00K | $100.00K | $100.00K | $160.00K |
| # Analysts | - | 1 | 1 | 1 | 1 | 10 |
| Surprise % | - | - | - | - | - | - |
Nemaura Medical's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. NMRD's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Nemaura Medical EBITDA Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Sep 21 | |
|---|---|---|---|---|---|---|
| # Analysts | - | 1 | 1 | 1 | 1 | 10 |
| EBITDA | - | - | - | $-1.46M | $-1.92M | $-1.67M |
| Avg Forecast | - | $40.00K | $60.00K | $20.00K | $20.00K | $-1.06M |
| High Forecast | - | $40.00K | $60.00K | $20.00K | $20.00K | $-849.80K |
| Low Forecast | - | $40.00K | $60.00K | $20.00K | $20.00K | $-1.27M |
| Surprise % | - | - | - | -73.05% | -95.97% | 1.57% |
undefined analysts predict NMRD's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Nemaura Medical's previous annual EBITDA (undefined) of $NaN.
Nemaura Medical Net Income Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Sep 21 | |
|---|---|---|---|---|---|---|
| # Analysts | - | 1 | 1 | 1 | 1 | 10 |
| Net Income | - | - | - | $-2.16M | $-1.20M | $-3.49M |
| Avg Forecast | $44.43M | $-3.18M | $-2.89M | $-2.89M | $-2.89M | $-2.22M |
| High Forecast | $44.43M | $-3.18M | $-2.89M | $-2.89M | $-2.89M | $-1.78M |
| Low Forecast | $44.43M | $-3.18M | $-2.89M | $-2.89M | $-2.89M | $-2.67M |
| Surprise % | - | - | - | 0.75% | 0.42% | 1.57% |
Nemaura Medical's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. NMRD's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Nemaura Medical SG&A Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Sep 21 | |
|---|---|---|---|---|---|---|
| # Analysts | - | 1 | 1 | 1 | 1 | 10 |
| SG&A | - | - | - | $1.25M | $1.56M | $1.43M |
| Avg Forecast | - | $3.52M | $5.28M | $1.76M | $1.76M | $3.52M |
| High Forecast | - | $3.52M | $5.28M | $1.76M | $1.76M | $4.22M |
| Low Forecast | - | $3.52M | $5.28M | $1.76M | $1.76M | $2.81M |
| Surprise % | - | - | - | 0.71% | 0.89% | 0.41% |
Nemaura Medical's average Quarter SG&A projection for Mar 24 is $5.28M, based on 1 Wall Street analysts, with a range of $5.28M to $5.28M. The forecast indicates a 322.05% rise compared to NMRD last annual SG&A of $1.25M (Dec 23).
Nemaura Medical EPS Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Sep 21 | |
|---|---|---|---|---|---|---|
| # Analysts | - | 1 | 1 | 1 | 1 | 10 |
| EPS | - | - | - | $-0.07 | $-0.04 | $-0.15 |
| Avg Forecast | $1.54 | $-0.11 | $-0.10 | $-0.10 | $-0.10 | $1.25 |
| High Forecast | $1.54 | $-0.11 | $-0.10 | $-0.10 | $-0.10 | $1.25 |
| Low Forecast | $1.54 | $-0.11 | $-0.10 | $-0.10 | $-0.10 | $1.25 |
| Surprise % | - | - | - | 0.75% | 0.42% | -0.12% |
According to undefined Wall Street analysts, Nemaura Medical's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to NMRD previous annual EPS of $NaN (undefined).